Helicobacter pylori culture and antimicrobial resistance in Iran

Indian Journal of Pediatrics

Volumn 74, Issue 2, 2007, Pages 127-130

  Fallahi, Gholam Hossein ^a,c   Maleknejad, Shohreh ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c NONE   (Iran)

Author keywords

Drug resistance; Endoscopy; H. Pylori; Pediatric

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; ERYTHROMYCIN; FURAZOLIDONE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; TETRACYCLINE; UREASE; ANTIINFECTIVE AGENT;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BURN; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOSCOPIC BIOPSY; FEMALE; GASTRITIS; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; INJURY; IRAN; MALE; NONHUMAN; PEDIATRICS; PEPTIC ULCER; PREVALENCE; DRUG EFFECT; DYSPEPSIA; FOLLOW UP; GASTROSCOPY; HELICOBACTER INFECTION; IMMUNOHISTOCHEMISTRY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; NEEDLE BIOPSY; PRESCHOOL CHILD; PROBABILITY; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BIOPSY, NEEDLE; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METRONIDAZOLE; MICROBIAL SENSITIVITY TESTS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 33947732355     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12098-007-0003-4     Document Type: Article

References (18)

1. Frenck RW Jr, Clemens J. Helicobacter in the developing world. Microbes Infect 2003; 5: 705-713.
2. Gottrand F, Turck D. Helicobacter pylori infection in children. Arch Pediatr 1995; 2: 573-579.
3. Brown LM. Helicobacter pylori: epidemiology and routs of transmission. Epidemiol Rev 2000; 22: 283-297.
4. Duck WM, Sobel J, Pruckler JM, Song Q, Swerdlow D, Friedman C et al. Antimicrobial resistance incidence and risk factors among Helicobacter pylori-infected persons, United States. Emerg Infect Dis 2004; 10: 1088-1094.
5. Labenz J. Consequences of Helicobacter pylori cure in ulcer patients. Baillieres Best Pract Res Clin Gastroenterol 2000; 14: 133-145.
6. Kalach N, Bergeret M, Benhamou PH, Dupont C, Raymond J. High levels of resistance to metronidazole and clarithromycin in Helicobacter pylori strains in children. J Clin Microbiol 2001; 39: 394-397.
7. Hoffman JSC, David R. Treatment of Helicobacter pylori. Curr Opin Gastroenterol 2001; 17: 30-34.
8. Adamek R J, Suerbaum S, Pfaffenbach B, Opferkuch W. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin-influence on treatment outcome. Am J Gastroenterol 1998; 93: 386-389.
9. Kim JJ, Reddy R, Lee M, Kim JG, El-Zaatari FA, Osato MS et al. Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother 2001; 47: 459-461.
10. Tolia V, Brown W, El-Baba M, Lin CH. Helicobacter pylori culture and antimicrobial susceptibility from pediatric patients in Michigan. Pediatr Infect Dis J 2000; 19: 1167-1171.
11. Wolle K, Leodolter A, Malfertheiner P, Konig W. Antibiotic susceptibility of Helicobacter pylori in Germany: stable primary resistance from 1995 to 2000. J Med Microbiol 2002; 51: 705-709.
12. Shashidhar H, Peters JM, Lin CH, Rabah R, Thomas R, Tolia V. A prospective trial of lansoprazole triple therapy for pediatric Helicobacter pylori infection. J Pediatr Gastroenterol Nutr 2000; 30: 276-282.
13. van der Wouden EJ, van Zwet AA, Vosmaer GD, Oom JA, de Jong A, Kleibeuker JH. Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands. Emerg Infect Dis 1997; 3: 385-389.
14. Sisson G, Jeong JY, Goodwin A, Bryden L, Rossler N, Lim-Morrison S et al. Metronidazole activation is mutagenic and causes DNA fragmentation in Helicobacter pylori and in Escherichia coli containing a cloned H. pylori RdxA(+) (Nitroreductase) gene. J Bacteriol 2000; 182: 5091-5096.
15. Malaty HM, Kim JG, Kim SD, Graham DY. Prevalence of Helicobacter pylori infection in Korean children: inverse relation to socioeconomic status despite a uniformly high prevalence in adults. Am J Epidemiol 1996; 143: 257-262.
16. Cayla R. How to eradicate Helicobacter pylori? Gastroenterol Clin Biol 1996; 20(1 Pt 2): S119-S130.
17. Lin TKW, Cheng AFB, Sung JJY, Yiu PYL, Chung SSC. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year study. Helicobacter 1996; 2: 185-187.
18. Fakheri H, Malekzadeh R, Merat S, Khatibian M, Fazel A, Alizadeh BZ et al. Clarithromycin vs. Furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate. Aliment Pharmacol Ther 2001; 15: 411-416.